August 11, 2010 
Accutane is a medication used for the treatment of severe cases of acne, especially those linked to permanent and disfiguring scarring such as acne vulgaris, acne conglobata and acne fulminans.
This drug is related to vitamin A, which makes it classified as a retinoid. Most dermatologists and physicians prescribe Accutane for management of acne. Since there are high risks for developing side effects, it is often not used as the first course of treatment. Deep facial cleansers, herbal skin care creams and topical ointments are usually the first round of treatments patients will receive. These alternative methods have become more popular due to the side effects one can develop from using drugs such as Accutane.
Physicians have also utilized the drug to treat Harlequin-type-ichthyosis, a rare condition that causes the skin to present plating as thick as armor after birth. Accutane has also been used sparsely to treat certain types of cancers including pancreatic and brain cancer. However, the drug may work throughout the body in killing cells not related to cancers.
Accutane is linked to the development of severe side effects, including inflammatory bowel disease, which has prompted many patients to file an Accutane lawsuit to seek compensation for medical bills, pain and suffering. In a 2006 study conducted by The American Journal of Gastroenterology, treatment with Accutane was noted as a possible “trigger” for inflammatory bowel disease. Frequently referred to as IBD, inflammatory bowel disease is a gastrointestinal disorder that refers to two chronic conditions that cause inflammation of the digestive tract, known as ulcerative colitis and Crohn’s disease.
According to a 2010 study published in The American Journal of Gastroenterology, Accutane may nearly quadruple a patient’s risk of developing ulcerative colitis, a chronic inflammatory bowel disease that requires the surgical removal of the colon in 25 to 40 percent of all cases. The study also reported that the risk of developing ulcerative colitis was highest in patients who used Accutane for more than two months.
Despite the fact that a possible association between Accutane and IBD was first discovered in the early 1980s, Accutane contained no warning of an increased risk of IBD for the majority of the time it was available on the market. A number of patients who have suffered these side effects argue that Roche Pharmaceuticals did not adequately warn them about Accutane’s risks. Please be sure to speak or receive a checkup with a dermatologist prior to making a decision.
By providing FDA alerts, drug information and drug side effects about prescription and over the counter medications, we can ensure an environment where patients have the best knowledge on their medical treatment and health. Additional information may be found on DrugWatch.com.
